Newsletter
Sign Up And Receive Our Latest Promotions!
Thank you! Your submission has been received!
.svg){kind=small}
DISEASE APPS FOR CLINICS
ACTIONABLE INSIGHTS FOR RETINAL DISEASES
Unlock insights with RetinAI Disease Evaluation Apps now!
Dive deeper into patient-level disease understanding by generating insightful reports on Heidelberg Heyex 2! Choose the "Launch Offer" below, and get your first 25 credits, for FREE!
Plans & Pricing
LAUNCH OFFER
FREE
Get your first 25 credits,
for free!
for free!
25 Credits
dryAMD App
nAMD App
DR/DME App
CME App
GA App
BASIC
500€
Price/credit: 5€
Credits expire in 12 mo.
Credits expire in 12 mo.
100 Credits
dryAMD App
nAMD App
DR/DME App
CME App
GA App
LITE
1750€
Price/credit: 3.5€
Credits expire in 36 mo.
Credits expire in 36 mo.
500 Credits
dryAMD App
nAMD App
DR/DME App
CME App
GA App
PLUS
2750€
Price/credit: 2.75€
Credits expire in 36 mo.
Credits expire in 36 mo.
1000 Credits
dryAMD App
nAMD App
DR/DME App
CME App
GA App
ULTIMATE
5000€
Price/credit: 2.5€
Credits expire in 36 mo.
Credits expire in 36 mo.
2000 Credits
dryAMD App
nAMD App
DR/DME App
CME App
GA App
Running Low on Credits? Recharge Here!
Already an esteemed RetinAI customer?
Refill your AppWay credits now to continuously leverage expert-level analysis of OCT volumes,
enhancing your decision-making and optimizing patient care outcomes.
Want to earn more free credits?
Join our Referral Program and get 10 free credits as soon as your Referral code is used! More information here
Interested in batch data analysis using AI?
Please note that our Disease Evaluation Apps via AppWay are meant to provide insights during a patient‘s visit. If you are interested in batch data analysis using AI, please consider our Discovery CORE solution for at-scale analysis or contact us at sales@retinai.com to find together the best solution for your needs
PLEASE READ AND UNDERSTAND THE FOLLOWING DISCLAIMERS
Not a diagnostic: Please be advised that RetinAI Appway Apps is not intended to be a substitute for medical advice, diagnosis or treatment.
Not a complete analysis of the disease concerned: Please be advised that that RetinAI Appway Apps is not intended to be a complete set of analyses for investigation of the disease area concerned.
Liability: Use of RetinAI Appway Apps is at your own risk. You must evaluate and take all responsibility associated with the use of any tool – RetinAI does not warrant any reliance on the accuracy, completeness or usefulness of any part or content.
Not a complete analysis of the disease concerned: Please be advised that that RetinAI Appway Apps is not intended to be a complete set of analyses for investigation of the disease area concerned.
Liability: Use of RetinAI Appway Apps is at your own risk. You must evaluate and take all responsibility associated with the use of any tool – RetinAI does not warrant any reliance on the accuracy, completeness or usefulness of any part or content.
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Certifications
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2023 ©
